Clinical Study to Evaluate the Effect of Shubhdeep Kidney Care Pill in the Management of Mutrakricchra w.s.r to UTI

Shruti Sharma, Umesh N. Patil, A. Shrivastava, Nagendra Singh Raghuvanshi
{"title":"Clinical Study to Evaluate the Effect of Shubhdeep Kidney Care Pill in the Management of Mutrakricchra w.s.r to UTI","authors":"Shruti Sharma, Umesh N. Patil, A. Shrivastava, Nagendra Singh Raghuvanshi","doi":"10.47223/irjay.2022.51201","DOIUrl":null,"url":null,"abstract":"Introduction Mutrakricchra (Urinary tract infection) is a prevalent illness that affects people of all ages. Disease incidence and prevalence differ by age and gender. Urinary tract infection and its treatment are critical since it can result in immediate morbidity as well as long-term problems such as hypertension and chronic renal insufficiency. Materials and methods 30 subjects had a 45-day clinical assessment of the test drug. Patients visiting the O.P.D. and I.P.D. of the P.G. Department of Kayachikitsa, Shubhdeep Ayurveda Medical College & Hospital (P.G Institute), Indore, participated in an open clinical study. Based on inclusion and exclusion criteria, patients of both sexes between the gender of 20 and 50 years were chosen. 500mg of the trial medication were administered twice daily with lukewarm water before meals. For the purpose of observing and evaluating the therapeutic effect, a case record form was created. Results were evaluated using both subjective and objective criteria. The paired \"t\" test was used to statistically analyze the demographic and clinical data. Results It was observed that in the present study, highest number of patients around 50% (15) had marked mild improvement in their subjective complaints and 23% (7) had good improvement, around 20% (6) of patients showed moderate improvement and 7% showed no/ poor relief. Discussion The formulations utilized in this study have components high in madhura, tikta- ras, sita-virya, laghu, snigdha-guna, and madhura -vipaka, which aided to reduce pitta dosha and daha. Vatashaman, shothaharan, and bastishodhan are made easier by the antibacterial and antimicrobial components","PeriodicalId":431628,"journal":{"name":"International Research Journal of Ayurveda & Yoga","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Research Journal of Ayurveda & Yoga","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47223/irjay.2022.51201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Mutrakricchra (Urinary tract infection) is a prevalent illness that affects people of all ages. Disease incidence and prevalence differ by age and gender. Urinary tract infection and its treatment are critical since it can result in immediate morbidity as well as long-term problems such as hypertension and chronic renal insufficiency. Materials and methods 30 subjects had a 45-day clinical assessment of the test drug. Patients visiting the O.P.D. and I.P.D. of the P.G. Department of Kayachikitsa, Shubhdeep Ayurveda Medical College & Hospital (P.G Institute), Indore, participated in an open clinical study. Based on inclusion and exclusion criteria, patients of both sexes between the gender of 20 and 50 years were chosen. 500mg of the trial medication were administered twice daily with lukewarm water before meals. For the purpose of observing and evaluating the therapeutic effect, a case record form was created. Results were evaluated using both subjective and objective criteria. The paired "t" test was used to statistically analyze the demographic and clinical data. Results It was observed that in the present study, highest number of patients around 50% (15) had marked mild improvement in their subjective complaints and 23% (7) had good improvement, around 20% (6) of patients showed moderate improvement and 7% showed no/ poor relief. Discussion The formulations utilized in this study have components high in madhura, tikta- ras, sita-virya, laghu, snigdha-guna, and madhura -vipaka, which aided to reduce pitta dosha and daha. Vatashaman, shothaharan, and bastishodhan are made easier by the antibacterial and antimicrobial components
舒肾深护丸治疗黄曲霉致尿路感染的临床研究
尿路感染是一种影响所有年龄人群的流行疾病。疾病发病率和流行率因年龄和性别而异。尿路感染及其治疗是至关重要的,因为它可以导致立即发病以及长期问题,如高血压和慢性肾功能不全。材料与方法30例受试者对试验药物进行为期45天的临床评估。到印度Shubhdeep阿育吠陀医学院和医院(P.G.研究所)Kayachikitsa P.G.部的O.P.D.和I.P.D.就诊的患者参加了一项公开的临床研究。根据纳入和排除标准,选择年龄在20 - 50岁之间的男女患者。试验用药500mg,每日两次,餐前用温水给药。为观察和评价治疗效果,制作病例记录表。使用主观和客观标准对结果进行评估。采用配对“t”检验对人口学和临床资料进行统计学分析。结果观察到,在本研究中,最多的患者约50%(15)的主观主诉有轻度改善,23%(7)的主观主诉有良好改善,约20%(6)的主观主诉有中度改善,7%的主观主诉无缓解或缓解差。本研究中使用的配方含有高含量的中草药、提克塔-拉斯、西塔-维里亚、laghu、snigha -guna和中草药,有助于减少皮塔多沙和达哈。Vatashaman, shothaharan和bastishodhan由于抗菌和抗菌成分而变得更容易
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信